Reliance Retail takes Netmeds offline with Chennai pharmacy store

Reliance Retail has opened a Netmeds physical store in Chennai, extending its e-pharmacy brand into offline retail and signalling an omnichannel push in pharmacy.

— FiledTue, 25 Aug, 2026, 12:48 IST·First seen Tue, 25 Aug, 2026, 12:48 IST·Source Inc42 · Quick Commerce

What happened

Reliance Retail entered offline pharmaceutical retail by opening a Netmeds store in Chennai, extending the e-pharmacy brand into physical retail.

Why this matters

The move makes Netmeds a more integrated healthcare retail platform and could create partnership or acquisition opportunities across diagnostics, clinics and last-mile delivery.

What to watch

  • Number, geography and format of follow-on Netmeds physical stores within the next 6-12 months.
  • Evidence of app-store integration such as pickup, local delivery promises, shared loyalty benefits or unified inventory visibility.
  • Store assortment mix: prescription drugs versus OTC, wellness, diagnostics and private-label products.
  • Announcements on Netmeds franchise, clinic, diagnostic-lab, insurer or hospital partnerships.
  • Competitor launches of denser delivery networks, store-linked pickup or pharmacy loyalty programs in Chennai and other metros.
  • Regulatory developments involving e-pharmacy licensing, prescription verification, discounting or drug-sale compliance.
  • Open additional Netmeds pilot stores in Chennai and other high-density metros, likely near residential catchments or existing Reliance locations.
  • Link store inventory to the Netmeds app for click-and-collect, scheduled refills, rapid local delivery and prescription upload support.
  • Use membership, private-label wellness products and cross-selling of diagnostics, personal care and FMCG to lift low pharmacy margins.
  • Strengthen local medicine procurement, licensed pharmacist staffing and cold-chain capabilities to support same-day fulfilment.
  • Test partnerships with clinics, diagnostic labs, insurers and corporate-health programs to build recurring prescription demand.